EirGen Pharma

EirGen Pharma was established in 2005 by former executives of IVAX Pharmaceuticals, Patsy Carney and Tom Brennan, now CEO and CTO, respectively. EirGen specialises in the development, registration and commercial supply of specialised pharmaceutical products that are mainly used in cancer treatment. EirGen's key markets currently are the EU, U.S., Japan and the Middle East. The company is fully U.S. FDA, EMA and Saudi FDA approved. EirGen was acquired by OPKO Health Inc. in 2015.